Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 – 35 wGA
Condition(s):Premature InfantsLast Updated:August 21, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Premature InfantsLast Updated:August 21, 2012Completed
Condition(s):Gynecological DisorderLast Updated:September 16, 2020Completed
Condition(s):Injection Fear; Injection Site Bruising; Pain, Acute; Satisfaction, Patient; HematomaLast Updated:March 25, 2024Completed
Condition(s):General Anesthesia and Bronchoscopy SedationLast Updated:September 22, 2022Not yet recruiting
Condition(s):Anesthesia, Local; Anesthesia, DentalLast Updated:May 20, 2008Completed
Condition(s):Pruritus VulvaeLast Updated:December 17, 2021Completed
Condition(s):AnesthesiaLast Updated:December 14, 2023Not yet recruiting
Condition(s):Induction of AnaesthesiaLast Updated:August 13, 2014Completed
Condition(s):Etomidate is Mixed With PropofolLast Updated:February 26, 2019Unknown status
Condition(s):Gastroscopic and Colonoscopic SedationLast Updated:February 24, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.